Literature DB >> 14985315

Effects of indocyanine green on retinal ganglion cells.

Aya Iriyama1, Saiko Uchida, Yasuo Yanagi, Yasuhiro Tamaki, Yuji Inoue, Kyosuke Matsuura, Kazuaki Kadonosono, Makoto Araie.   

Abstract

PURPOSE: Recently, indocyanine green (ICG) has been used to visualize the internal limiting membrane during vitrectomy. After intraocular administration, ICG accumulates at the optic disc. In this study, the effects of ICG on retinal ganglion cells (RGCs) were examined.
METHODS: In vitro, rat RGCs were purified by a two-step immunopanning procedure, briefly exposed to ICG (2.5 x 10(3) mg/L), and irradiated with an endoilluminator for 15 minutes or incubated in the presence of ICG (concentration: 2-250 mg/L) without irradiation. The number of viable RGCs was counted after 3 days in culture. In vivo, after rats received an intravitreal injection of 3 micro L ICG (0.25 and 2.5 mg/L), the distribution of ICG was observed with a fundus camera, and the number of viable RGCs was examined by a DiI (1,1'-dioctadecyl-1-3,3,3',3'-tetramethylindocarbocyanine perchlorate)-retrolabeling technique.
RESULTS: In vitro, a brief exposure to ICG and light did not affect RGC survival. However, ICG reduced the number of viable RGCs in a dose-dependent manner when the cells were exposed for 3 days. In vivo, the dye was initially distributed on the retinal surface and around the optic disc. At day 7, the fluorescence became invisible in the 0.25-mg/L group, whereas the staining of the optic disc contour was evident in the 2.5-mg/L group. The number of viable RGCs decreased significantly in the 2.5-mg/L group 14 days after the injection.
CONCLUSIONS: ICG showed an inherent toxicity to RGCs in a dose-dependent manner. Lower concentration and shorter staining time of ICG should be used for dye-assisted vitrectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985315     DOI: 10.1167/iovs.03-1026

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

1.  Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

2.  Retinal nerve fibre layer damage after indocyanine green assisted vitrectomy.

Authors:  A Iriyama; Y Yanagi; S Uchida; Y Tamaki; M Aihara; R Obata; Y Inoue
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Indocyanine green accused.

Authors:  T L Jackson
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Chromovitrectomy: a new field in vitreoretinal surgery.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Peter Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

5.  Let green lead not astray.

Authors:  J Sebag
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

6.  Which colour suits the vitreoretinal surgeon?

Authors:  Nanny Collaer; Peter Stalmans
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

7.  Reduction of thickness of ganglion cell complex after internal limiting membrane peeling during vitrectomy for idiopathic macular hole.

Authors:  T Baba; S Yamamoto; R Kimoto; T Oshitari; E Sato
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

8.  Involvement of illumination in indocyanine green toxicity after its washout in the ex vivo rat retina.

Authors:  Kazuhiro Tokuda; Charles F Zorumski; Yukitoshi Izumi
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

9.  Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.

Authors:  Shigeki Machida; Yoshiharu Toba; Tomoharu Nishimura; Takayuki Ohzeki; Ken-ichi Murai; Daijiro Kurosaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-02       Impact factor: 3.117

10.  Effect of anti-VEGF antibody on retinal ganglion cells in rats.

Authors:  Aya Iriyama; Yi-Ning Chen; Yasuhiro Tamaki; Yasuo Yanagi
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.